Couderc B - Search Results

1

Prevention of posterior capsule opacification by the induction of therapeutic apoptosis of residual lens cells.

Malecaze F, Decha A, Serre B, Penary M, Duboue M, Berg D, Levade T, Lubsen NH, Kremer EJ, Couderc B. Malecaze F, et al. Among authors: couderc b. Gene Ther. 2006 Mar;13(5):440-8. doi: 10.1038/sj.gt.3302667. Gene Ther. 2006. PMID: 16251995

2

Adenovirus-mediated suicide gene transduction: feasibility in lens epithelium and in prevention of posterior capsule opacification in rabbits.

Malecaze F, Couderc B, de Neuville S, Serres B, Mallet J, Douin-Echinard V, Manenti S, Revah F, Darbon JM. Malecaze F, et al. Among authors: couderc b. Hum Gene Ther. 1999 Sep 20;10(14):2365-72. doi: 10.1089/10430349950017013. Hum Gene Ther. 1999. PMID: 10515456

3

Lens cell targetting for gene therapy of prevention of posterior capsule opacification.

Malecaze F, Lubsen NH, Serre B, Decha A, Duboue M, Penary M, Berg D, Arnaud JD, Titeux M, Kremer EJ, Couderc B. Malecaze F, et al. Among authors: couderc b. Gene Ther. 2006 Oct;13(19):1422-9. doi: 10.1038/sj.gt.3302790. Epub 2006 May 25. Gene Ther. 2006. PMID: 16724094

4

In vivo restoration of RhoB expression leads to ovarian tumor regression.

Couderc B, Pradines A, Rafii A, Golzio M, Deviers A, Allal C, Berg D, Penary M, Teissie J, Favre G. Couderc B, et al. Cancer Gene Ther. 2008 Jul;15(7):456-64. doi: 10.1038/cgt.2008.12. Epub 2008 Mar 14. Cancer Gene Ther. 2008. PMID: 18340357

5

Retrovirus-mediated transfer of a suicide gene into lens epithelial cells in vitro and in an experimental model of posterior capsule opacification.

Couderc BC, de Neuville S, Douin-Echinard V, Serres B, Manenti S, Darbon JM, Malecaze F. Couderc BC, et al. Curr Eye Res. 1999 Dec;19(6):472-82. doi: 10.1076/ceyr.19.6.472.5284. Curr Eye Res. 1999. PMID: 10550788

6

Preclinical study of an ex vivo gene therapy protocol for hepatocarcinoma.

Lortal B, Gross F, Peron JM, Pénary M, Berg D, Hennebelle I, Favre G, Couderc B. Lortal B, et al. Among authors: couderc b. Cancer Gene Ther. 2009 Apr;16(4):329-37. doi: 10.1038/cgt.2008.88. Epub 2008 Nov 7. Cancer Gene Ther. 2009. PMID: 18989351

7

Reversible inactivation of the transcriptional function of P53 protein by farnesylation.

Couderc B, Penary M, Tohfe M, Pradines A, Casteignau A, Berg D, Favre G. Couderc B, et al. BMC Biotechnol. 2006 May 29;6:26. doi: 10.1186/1472-6750-6-26. BMC Biotechnol. 2006. PMID: 16732889 Free PMC article.

8

In vivo gene silencing in solid tumors by targeted electrically mediated siRNA delivery.

Golzio M, Mazzolini L, Ledoux A, Paganin A, Izard M, Hellaudais L, Bieth A, Pillaire MJ, Cazaux C, Hoffmann JS, Couderc B, Teissié J. Golzio M, et al. Among authors: couderc b. Gene Ther. 2007 May;14(9):752-9. doi: 10.1038/sj.gt.3302920. Epub 2007 Mar 8. Gene Ther. 2007. PMID: 17344906

9

Reversion of transformed phenotype of human adenocarcinoma A549 cells by expression of 3-hydroxy-3-methylglutaryl coenzyme A reductase complementary DNA.

Seronie-Vivien S, Pradines A, Couderc B, Clamagirand C, Berg D, Soula G, Favre G. Seronie-Vivien S, et al. Among authors: couderc b. Cell Growth Differ. 1995 Nov;6(11):1415-23. Cell Growth Differ. 1995. PMID: 8562480

10

The expression of CD70 and CD80 by gene-modified tumor cells induces an antitumor response depending on the MHC status.

Douin-Echinard V, Bornes S, Rochaix P, Tilkin AF, Peron JM, Bonnet J, Favre G, Couderc B. Douin-Echinard V, et al. Among authors: couderc b. Cancer Gene Ther. 2000 Dec;7(12):1543-56. doi: 10.1038/sj.cgt.7700268. Cancer Gene Ther. 2000. PMID: 11228533

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

81 results

Search Page

Filters